Samplix is a groundbreaking brand that enables scientists to easily sequence any genomic region. With their microfluidics-based solutions, they provide high-resolution insights into cells and genomes, supporting life sciences and medical research communities. Their products are essential for a range of purposes, including functional analyses of single mammalian cells, verification of gene edits, and assessments of single-cell enzyme activity.

The brand's success is rooted in their innovative technology. In 2012, two scientists, Dr. Marie Just Mikkelsen and Dr.

Thomas Kvist, developed a method that eliminates errors and biases in genomic analyses. Their PCR amplification-free workflow, featuring single molecules encapsulated in droplets, revolutionized the field. In 2019, they launched Xdrop®, a fully developed microfluidics system for droplet-based, PCR-free enrichment of genomic regions.

Since then, the Xdrop technology has been proven effective in various applications with human, animal, plant, and microbial genomes. Samplix's management team, led by Lars Kongsbak, possesses vast expertise in building startups and commercial operations in the life sciences industry. The brand continues to grow globally, supporting researchers worldwide in their genomics and molecular biology endeavors.

Stay up-to-date with their latest news, product releases, webinars, and events by signing up for the Samplix newsletter. Visit their website to learn more about their vision and connect with them for potential partnerships and projects